U.S. Markets close in 4 hrs.
Stocks to Watch

Sempra outbids Buffett for Oncor, Fiat Chrysler soars, Nike gets downgraded

Opiant Pharmaceuticals, Inc. (OPNT)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
22.25-0.80 (-3.47%)
As of 11:10AM EDT. Market open.
People also watch
NTCTOIIMSPRTIPAROTEX
  • B
    BioNap
    BioNap

    SLNO (MC $18 M) BLOCKBUSTER in Phase 3 /Rare Disease & Orphan Status = REAL Unknown low float stock with 1000% upside Potential and more .Next billion dollar rare disease company like SRPT here .GLTA

    Soleno therapeutics (SLNO)

    Market Cap $18 Million
    Cash: $8 Million
    Price $0.37

    Shares Out: 47.6 Million ( 36 Million shares held by Insiders & Institutions)

    Initiating Coverage June 26, 2017
    http://www.lifescicapital.com/wp-content/uploads/Soleno.pdf

    •Company expects to initiate pivotal Phase III clinical trial by year-end 2017; will take approximately 9-12 months to complete

    Soleno Therapeutics, Inc. (Soleno) is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company is currently advancing its lead candidate, DCCR, a once-daily oral tablet for the treatment of PWS, into a Phase III clinical development program at the end of 2017.

    Market Opportunity for PWS is Substantial.

    While the lack of approved treatments for PWS alone make it difficult to assess the market, sales of Pfizer’s (NYSE: PFE)
    Genotrop in (somatropin) can provide some insight despite being indicate for PWS, in addition to, growth failure due to growth hormone deficiency(GHD),Turner syndrome,idiopathic short stature,and small for gestational age.This product achieved its highest revenue in 2008,with worldwide sales of approximately $900 million.While somatropin has been proven to improve growth and body composition, it does not affect the key disease component of hyperphagia and use is associated with substantial risk. Soleno is developing DCCR for the treatment of PWS,to help address the unmet need of this patient population. To assess the potential of DCCR for PWS, we performed a scenario analysis, which indicates that annual sales could be in the range of $1.1 billion given a moderate price point and 50% market penetrance.

  • R
    Raymond
    Raymond
    OPNT will NOT be doing a secondary option anytime soon if at all. Companies that practice this move are companies that are hurting for cash and have no source of revenue. Which is the exact opposite of OPNT. They have a source of revenue, zero debt, and 10 mil in cash that doesn't include the recent payment of 3.75mil. If they wanted to get a handle on their low float they would more than likely do a split of 5 to 1 around the time the stock was trading in the 40-50 range
  • p
    pinkpanther4056
    pinkpanther4056
    I have been long holder of OPNT and recently sold for some profit. I still believe in long-term prospects, but with such few outstanding shares, dramatic price rise, and stock options ready to be exercised, now would be a good time for them to do an offering, diluting share price. The market cap is small tho, so even after dilution, room for upside remains. Good luck everyone, glad to see OPNT finally start receiving recognition.
  • m
    michael
    michael
    Has everyone received "the" phone call yet? It's coming.
  • A
    Ann
    Ann
    after hours down 2.65? does anyone know why? I cant find any news??
  • R
    Robert
    Robert
    Here is your buying opportunity.
  • R
    Robert
    Robert
    Does anyone else find it ironic that Opiant's success relies on the opiate abuse remaining high?
  • K
    KD
    KD

    Not sure why people are so concern about dilution (which company give no indication). NARCAN drug is showing up everywhere and saving everyday. I think Walgreen and CVS are start carrying this drug and first responded and hospitals are using in very high demand. You have to look at bigger picture. I think company calculated pipeline cost and burn rate and came up with ~$17M number which they got it from SWK. But, now looking at NARCAN demand I think they will achieve their target goal well ahead of time and may not need additional fund till next FDA approval.

    http://www.chicagotribune.com/news/nationworld/midwest/indiana/ct-indiana-toddler-opiate-overdose-20170817-story.html

    Doctors treat Indiana toddler with Narcan after opiate overdose
    Police say doctors treated a central Indiana toddler with the overdose reversal drug Narcan after he apparently ingested opiates that he found.
    www.chicagotribune.com
  • A
    Anonymous
    Anonymous
    I don't have a position in OPNT, have been watching it for a week or so. Although there is demand for NARCAN but I don't agree with the notion that a prescription for NARCAN will be written with every prescription of Opiod. That is like thinking that each time someone buys a box of matches he will also buy a fire extinguisher!! Good luck to all.
  • T
    Todd
    Todd
    Nice reversal......going green for the day. I was wondering who was selling? I probably won't even start thinking about taking profit until it hits around $50.
  • K
    KD
    KD

    This thing is everywhere and saving life each day.

    http://abc7news.com/exclusive-campbell-cops-talk-about-using-narcan-to-save-man-from-overdose/2310973/

    EXCLUSIVE: Campbell cops talk about using Narcan to save man from overdose
    A man who had overdosed and nearly died inside a drug store is alive today thanks to Campbell police officers becoming the first in the county to use an opioid antidote.
    abc7news.com
  • R
    Raymond
    Raymond
    In the article below, the doctor that saved her life states that doses of NARCAN should be on board every flight.
  • K
    KD
    KD

    Very noble idea. Really good for OPNT. You guys can read through article and if you agree with thought process their is a link to sign petition..

    http://www.huffingtonpost.com/entry/lyft-uber-narcan-naloxone-overdose_us_59970b52e4b033e0fbdec36b

    Lyft And Uber Drivers Could Help Fight The Drug Epidemic With One Simple Tool
    Most drivers aren’t prepared for this situation, but they’re in a unique position to save a life.
    www.huffingtonpost.com
  • K
    KD
    KD
    He had point but, just take his example. Every house has fire extinguisher and need to check if it's in working condition all the time. Same for NARCAN spray, even you don't use it but, every prescription user should have that and make sure it's not expire. That's alone will make company worth around $100M. I haven't touch about AUD which has around $350M market cap, BN has another $200M to $300M mapket cap. If this company only grab 10% of overall market that means company worth around $150-$200M. Apart from that, this company has good momentum so, nothing wrong to be on positive side of momentum.
  • R
    Raymond
    Raymond
    Nice sell off in to close..
  • T
    Todd
    Todd
    It was fun while it lasted but volume has dried up and I didn't like the responses (or lack there of) from the investors relation people at Argot. I'm getting the impression shareholder's are not top priority and a dilution is coming shortly. I will keep my eyes open for another entry point but I'm thing sub $15.
  • R
    Raymond
    Raymond
    Damn I though me buying more an additional 500 shares at 17 was a gift.. I guess I could have waited until tomorrow morning. Oh well my first 1000 shares were bought in the $8 range. I'm not worried, we all know this stock moves up faster than it comes down. We will see new all time highs next week
  • R
    Robert
    Robert
    Imagejamieclaire
  • G
    Gregory C
    Gregory C
    OK well the news is out about the $3.75 million payment for NARCAN sales. Now the question is - was this the reason for the rise? People in the know? And it's now a buy the rumor sell the news situation? Or...will it continue to rise after this news?